Treatment of Ulcerative Colitis based on Cohosh-atractylodes

Abstract

Ulcerative colitis (UC), also known as chronic nonspecific ulcerative colitis, is a chronic inflammatory bowel disease of unknown etiology. The disease is characterized by frequent diarrhea, tenesmus, crampy abdominal pain, mucus, pus, and bloody stools [1] . According to the existing statistics in China, the prevalence and incidence of ulcerative colitis are increasing year by year, and it has become a common and frequent disease in China, and the treatment methods of modern medicine are limited, and the combination of traditional Chinese and Western medicine in the treatment of ulcerative colitis will have better efficacy and development. In the theoretical system of traditional chinese medicine, ulcerative colitis also belongs to the category of spleen and stomach diseases. In the history of traditional chinese medicine, Li Dongyuan, a physician who created the "spleen and stomach theory" of traditional chinese medicine, has a unique theoretical system and prescription system for the treatment of spleen and stomach diseases. Li Dongyuan is a clinical master of traditional chinese medicine, known as one of the "Four Masters of Jin Yuan" and "Replenishing Soil". His works "On the Spleen and Stomach" and "On the Distinction of Internal and External Injuries" laid an important foundation for the development of the "Theory of the Spleen and Stomach". After researching these works, the author found that Li Dongyuan's prescription medicine is mostly cold and hot drugs, among which cohosh-atractylodes is one of Li Dongyuan's commonly used drug pairs. After clinical and modern research, this pair of drugs has a good therapeutic and regulatory effect on ulcerative colitis. However, in clinical practice, these two drugs have not been widely used, and further discussion and research are needed.